ERN1 and glioblastoma: As there are known connections between lipogenesis and the UPR (Figure 2), particularly via the IRE1/XBP-1 axis [79], and that link extends to FASN [80], combination therapies that disrupt long chain fatty acid synthesis in conjunction with targets involved in the UPR may have value in future GBM treatment strategies.